Inventor
David Carroll
Inventor
San Francisco, CA, US
Overview
Patents· 94 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
C07DHeterocyclic compounds14%
A61KPreparations for medical, dental or toiletry purposes11%
B82YSpecific uses or applications of nanostructures4%
H01LSemiconductor devices4%
H10KOrganic electric solid-state devices4%
Y02EReduction of greenhouse gas [ghg] emissions, related to energy generation, transmission or distribution3%
C07BGeneral methods of organic chemistry2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
A61LMethods or apparatus for sterilising materials or objects in general2%
PatentTitleYear
11,101,439Thin-film PN junctions and applications thereof202110,941,134AMPK-activating heterocyclic compounds and methods for using the same202110,882,645Guideless resilient androgynous serial port docking mechanism202110,868,077Thermoelectric apparatus and applications thereof202010,840,426Thermoelectric apparatus and articles and applications thereof202010,724,480Monofilament vaporization propulsion systems202010,632,235Devices and methods for treating spinal cord tissue202010,570,892Fiber-fed advanced pulsed plasma thruster (FPPT)202010,566,536Optoelectronic devices and applications thereof202010,547,006Phase separated composite layers and applications thereof202010,446,373Cyclotronic plasma actuator with arc-magnet for active flow control201910,421,752Compositions and methods for inhibition of the JAK pathway201910,377,742AMPK-activating heterocyclic compounds and methods for using the same201910,332,724Cyclotronic plasma actuator with arc-magnet for active flow control201910,259,826Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds201910,121,993Frequency dependent light emitting devices201810,076,318Apparatus and method for cardiac tissue modulation by topical application of vacuum to minimize cell death and damage201810,040,766Ubiquitination inhibitors20189,909,574'Electrothermal space thruster heater for decomposable propellants'20189,905,810'Frequency dependent light emitting devices'20189,751,893'Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds'20179,732,073'Compositions and methods for inhibition of the JAK pathway'20179,725,419'Cycloalkyl substituted pyrimidinediamine compounds and their uses'20179,728,725'Light emmiting device comprising conjugated terpolymer/teroligomer capable of white light emittion'20179,679,672'Low band gap conjugated polymeric compositions and applications thereof'20179,671,301'Small-scale pressure sensors'20179,598,432'2,4-pyrimidinediamine compounds and uses as anti-proliferative agents'20179,593,082'Compositions and methods for inhibition of the JAK pathway'20179,481,654'Compositions and methods for inhibition of the JAK pathway'20169,464,948'Strain gauge and applications thereof'20169,409,884'5- or 6-substituted benzofuran-2-carboxamide compounds and methods for using them'20169,318,721'Field induced polymer electroluminescent (FIPEL) device'20169,289,193'Apparatus and method for cardiac tissue modulation by topical application of vacuum to minimize cell death and damage'20169,266,856'AMPK—activating heterocyclic compounds and methods for using the same'20169,248,190'Compositions and methods for inhibition of the JAK pathway'20169,242,747'Space thruster using robust microcavity discharge and advanced propellants'20169,131,927'Apparatus and method for cardiac tissue modulation by topical application of vacuum to minimize cell death and damage'20159,105,848'Composite organic materials and applications thereof'20159,040,543'Compositions and methods for inhibition of the JAK pathway'20158,993,363'Optoelectronic devices and applications thereof'20158,987,303'AMPK-activating heterocyclic compounds and methods for using the same'20158,980,921'AMPK-activating heterocyclic compounds and methods for using the same'20158,962,643'Compositions and methods for inhibition of the JAK pathway'20158,861,921'Photovoltaic device with frequency conversion region'20148,834,520'Devices and methods for treating spinal cord tissue'20148,815,848'Compositions and methods for inhibition of the JAK pathway'20148,809,370'AMPK-activating heterocyclic compounds and methods for using the same'20148,809,341'2,4-pyrimidinediamine compounds and uses as anti-proliferative agents'20148,791,136'Substituted pyridine, pyridazine, pyrazine and pyrimidine compounds and methods for using the same'20148,772,629'Fiber photovoltaic devices and applications thereof'20148,764,794'Device and method for treating central nervous system pathology'20148,729,087'Compositions and methods for inhibition of the JAK pathway'20148,689,537'Micro-cavity discharge thruster (MCDT)'20148,603,855'Optoelectronic devices and applications thereof'20138,558,105'Organic optoelectronic devices and applications thereof'20138,501,233'Compositions and methods for treating cancer'20138,476,820'Solid state lighting compositions and systems'20138,415,365'Compositions and methods for inhibition of the JAK pathway'20138,410,093'Cycloalkyl substituted pyrimidinediamine compounds and their uses'20138,399,472'Compositions and methods for inhibition of the JAK pathway'20138,304,422'Compositions and methods for inhibition of the JAK pathway'20128,299,087'Compositions and methods for inhibition of the JAK pathway'20128,267,960'Device and method for treating central nervous system pathology'20128,252,772'Hyperthermic technologies and therapeutic uses thereof'20128,193,197'Compositions and methods for inhibition of the JAK pathway'20128,178,671'Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds'20127,947,698'Compositions and methods for inhibition of the JAK pathway'20117,915,273'Compositions and methods for inhibition of the JAK pathway'20117,884,111'2,4-pyrimidinediamine compounds and uses as anti-proliferative agents'20117,868,013'Cycloalkyl substituted pyrimidinediamine compounds and their uses'20117,858,633'Cycloalkyl substituted pyrimidinediamine compounds and their uses'20107,834,077'Halogen containing-polymer nanocomposite compositions, methods, and products employing such compositions'20107,834,024'Compositions and methods for inhibition of the JAK pathway'20107,804,877'Atomic lasers with exciplex assisted absorption'20107,754,714'Cycloalkyl substituted pyrimidinediamine compounds and their uses'20107,750,071'Halogen containing-polymer nanocomposite compositions, methods, and products employing such compositions'20107,585,883'Substituted pyridines and their uses'20097,560,466'Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds'20097,491,732'Compositions and methods for inhibition of the JAK pathway'20097,482,351'4-pyrimidineamine compounds and their uses as anti-proliferative agents'20097,452,879'Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds'20087,274,724'Method, system and apparatus for an enhanced electrically pumped oxygen iodine laser'20077,265,174'Halogen containing-polymer nanocomposite compositions, methods, and products employing such compositions'20077,206,114'Plasmon-photon coupled optical devices'20077,122,542'Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds'20067,110,154'Plasmon-photon coupled optical devices'20066,977,509'System and method for high voltage testing of twisted insulated conductors'20056,947,208'Optical fiber amplifier with fully integrated pump source'20056,833,201'Nanostructured-doped compound for use in an EL element'20046,501,780'Method, system and apparatus for an electrically assisted chemical oxygen iodine laser'20024,951,841'Dispensing container made from an ethylene vinyl alcohol containing laminated material and the material therefor'19904,693,395'Ethylene propylene copolymer in a substrate and collapsible dispensing container made therefrom'19874,608,285'Laminated substrate and collapsible dispensing container made therefrom'19864,080,441'Antibacterial oral composition'1978Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2002–2018Based in Urbana, IL, US· patent location history
2004–2010Based in Central, SC, US· patent location history
2005–2020Patents assigned to CARROLL DAVID L (13)· patent assignee history
2006–2021Patents assigned to RIGEL PHARMACEUTICALS INC (43)· patent assignee history
2006–2021Based in San Francisco, CA, US· patent location history
2006–2021Based in Winston-Salem, NC, US· patent location history
2012–2021Patents assigned to UNIV WAKE FOREST (20)· patent assignee history
2012–2017Patents assigned to CARROLL DAVID (14)· patent assignee history
2012–2017Patents assigned to SINGH RAJINDER (14)· patent assignee history
2019–2021Based in Champaign, IL, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| RIGEL PHARMACEUTICALS INC | 43 | 2006–2021 |
| UNIV WAKE FOREST | 20 | 2012–2021 |
| CARROLL DAVIDself | 14 | 2012–2017 |
| SINGH RAJINDER | 14 | 2012–2017 |
| CARROLL DAVID Lself | 13 | 2005–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Francisco, California, US | 43 | 2006–2021 |
| Winston-Salem, NC, US | 30 | 2006–2021 |
| Urbana, Illinois, US | 6 | 2002–2018 |
| Champaign, Illinois, US | 5 | 2019–2021 |
| Central, SC, US | 5 | 2004–2010 |